[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582876":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":86,"collaborators":7,"id":88,"slug":89,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":90,"sex":96,"minAge":97,"maxAge":98,"enrollmentInfo":99,"targetDuration":7,"studyType":102,"phases":7,"briefSummary":103,"conditions":104,"keywords":107,"overallStatus":110,"whyStopped":7,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Rennes University Hospital","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"BARF scale","BARF Scale, validated in paediatrics, is graduated from 0 to 10 and shows 6 increasingly nauseous faces. A child\u002Fadolescent will be considered \"at risk of NV\" if he\u002Fshe declares a score greater than or equal to 4 out of 10 on at least one of the 4 observation times.\n\nThis scale can be used by the child him\u002Fherself, from the age of 4; or by a close adult, usually present at the child's side during treatment.",[13],{"name":14,"affiliation":15,"role":16},"Maïna LETORT-BERTRAND","CHU Rennes Hôpital Sud","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Claude Pellen","CONTACT","0299282555","claude.pellen@chu-rennes.fr",{"name":24,"role":20,"phone":21,"phoneExt":7,"email":25},"Direction de la Recherche et de l'innovation","dri@chu-rennes.fr",[27,42,54,65,74],{"facility":28,"status":7,"city":29,"state":30,"zip":31,"country":30,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"CHU Angers","Angers","France","49933","FR",{"type":34,"coordinates":35},"Point",[36,37],-0.55202,47.47156,{"lat":37,"lon":36},[40],{"name":41,"role":20,"phone":7,"phoneExt":7,"email":7},"Rebecca VINAS JOLLY",{"facility":43,"status":7,"city":44,"state":30,"zip":45,"country":30,"countryCode":32,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"CHU Caen FEH","Caen","14033",{"type":34,"coordinates":47},[48,49],-0.35912,49.18585,{"lat":49,"lon":48},[52],{"name":53,"role":20,"phone":7,"phoneExt":7,"email":7},"Alexandra LAIGNEL",{"facility":5,"status":7,"city":55,"state":30,"zip":56,"country":30,"countryCode":32,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Rennes","35000",{"type":34,"coordinates":58},[59,60],-1.67431,48.11109,{"lat":60,"lon":59},[63,64],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},{"name":24,"role":20,"phone":21,"phoneExt":7,"email":25},{"facility":66,"status":7,"city":67,"state":30,"zip":68,"country":30,"countryCode":32,"cosmosGeoPoint":69,"geoPoint":73,"contacts":7},"Institut de Cancérologie de l'Ouest René Gauducheau","Saint-Herblain","44800",{"type":34,"coordinates":70},[71,72],-1.651,47.21154,{"lat":72,"lon":71},{"facility":75,"status":7,"city":76,"state":30,"zip":77,"country":30,"countryCode":32,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"CHU Tours Hôpital Clocheville","Tours","37044",{"type":34,"coordinates":79},[80,81],0.70398,47.39484,{"lat":81,"lon":80},[84],{"name":85,"role":20,"phone":7,"phoneExt":7,"email":7},"Anaïs COUTANT",{"type":87,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100582876","predict-chimio-or-radiation-induced-nausea-and-vomiting-in-childrenadolescents-treated-for-cancer-100582876",false,"NCT06869005","Predict CHimio-or Radiation-induced NAusea and Vomiting in Children\u002Fadolescents Treated for Cancer","Prévoir Les NAusées Et Vomissements CHimio Ou Radio-induits Chez Les Enfants\u002Fadolescents Traités Pour Un Cancer","PaNACHE","Inclusion Criteria:\n\n* Treated in a pediatric onco-hematology center in the GOCE (Grand Ouest Cancer Enfant) inter-region;\n* Receiving chemotherapy or radiotherapy;\n* According to patient age :\n* Minor (under 18 years): At least one parent has been informed of the protocol and has not expressed opposition to the child's participation in the study\n* Adult (more than 18 years): Having received information about the protocol and not having expressed opposition to participating in the study\n\nExclusion Criteria:\n\n* Patients or legal representatives with French understanding difficulties.\n* Patients or legal representatives subject with legal protection (safeguard of justice, curatorship, guardianship) or deprived of liberty.","ALL","4 Years","18 Years",{"count":100,"type":101},150,"ESTIMATED","OBSERVATIONAL","Chemo- or radiation-induced nausea and vomiting (CRVN) is one of the most frequent and feared side effects.\n\nIt is a symptom that is few or not at all evaluated. There is a significant discrepancy between the perception of the CRVN symptom by caregivers and the patient's own experience.\n\nAt present, there is no real consensus to manage CRVN with medication, and CRVN relief is also the subject of heterogeneous practices. The importance of primary prevention of CRVN, before starting the first treatment sequence, has been highlighted to optimize the action of antiemetic treatments and limit the risk of anticipated nausea and vomiting (NV).\n\nThe investigators' objective is to objectively assess the risk of CRVN in children\u002Fadolescents treated for cancer (and thus effectively prevent this symptom).",[105,106],"Childhood Cancer","Nausea with Vomiting Chemotherapy-Induced",[105,108,10,109],"Chemo- or Radiation-induced Nausea and Vomiting (CVRN),","PaNACHE score","NOT_YET_RECRUITING","2025-03-06",{"date":113,"type":114},"2025-03-11","ACTUAL",{"date":116,"type":101},"2025-03",{"date":118,"type":101},"2026-07",{"name":5,"class":6},5]